Phase I/II randomised study of a novel erythropoiesis-stimulating agent (AMG 114) for the treatment of anaemia with concomitant chemotherapy in patients with non-myeloid malignancies

  • Richard de Boer, Michael Clemens, Gabor Renczes, Dusan Kotasek, Jana Prausova, Norbert Marschner, Michael Hedenus, Sameer Doshi, Lisa Hendricks, Anders C. Österborg
  • Medical Oncology, October 2010, Springer Science + Business Media
  • DOI: 10.1007/s12032-010-9725-7

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication

The following have contributed to this page: Dr Norbert W Marschner